¼¼°èÀÇ ¸ÖƼÇ÷º½º ¾î¼¼ÀÌ ½ÃÀå
Multiplex Assays
»óǰÄÚµå : 1760783
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 158 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,124,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,373,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¸ÖƼÇ÷º½º ¾î¼¼ÀÌ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 60¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 41¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¸ÖƼÇ÷º½º ¾î¼¼ÀÌ ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 6.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 60¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼Ò¸ðǰÀº CAGR 6.9%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 37¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±â±â ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 5.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 11¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¸ÖƼÇ÷º½º ¾î¼¼ÀÌ ½ÃÀåÀº 2024³â¿¡ 11¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 14¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 9.6%·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.5%¿Í 6.1%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.8%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ¸ÖƼÇ÷º½º ¾î¼¼ÀÌ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

¸ÖƼÇ÷º½º ¾î¼¼ÀÌÀ̶õ ¹«¾ùÀ̸ç, Á¶»ç ¹× Áø´Ü¿¡ ¾î¶»°Ô »ç¿ëµË´Ï±î?

¸ÖƼÇ÷º½º ¾î¼¼ÀÌÀº ÇϳªÀÇ ½Ã·á¿¡¼­ ¿©·¯ »ý¹°ÇÐÀû ¸¶Ä¿(´Ü¹éÁú, À¯ÀüÀÚ, ±âŸ ºÐÀÚ µî)¸¦ µ¿½Ã¿¡ °ËÃâÇÏ°í ºÐ¼®ÇÒ ¼ö Àִ ÷´Ü Áø´Ü µµ±¸ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®Àº º¹ÀâÇÑ »ý¹°ÇÐÀû °úÁ¤À» ºÐ¼®Çϰųª º¸´Ù ³ôÀº Á¤È®µµ¿Í È¿À²·Î Áúº´À» °ËÃâÇϱâ À§ÇØ ¿¬±¸, ÀÓ»ó Áø´Ü, ÀǾàǰ °³¹ß¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÇÑ ¹ø¿¡ ÇϳªÀÇ ºÐ¼®¹°À» ÃøÁ¤ÇÏ´Â ±âÁ¸ ºÐ¼®¹ý°ú´Â ´Þ¸®, ¸ÖƼÇ÷º½º ¾î¼¼À̹ýÀº ¿©·¯ Ÿ°ÙÀ» µ¿½Ã¿¡ Æò°¡ÇÏ¿© Á¾ÇÕÀûÀÎ °³¿ä¸¦ Á¦°øÇÔÀ¸·Î½á ½Ã°£À» Àý¾àÇÏ°í ºñ¿ëÀ» Àý°¨ÇÏ¸ç µ¥ÀÌÅÍ Ã³¸®·®À» Çâ»ó½Ãŵ´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®Àº Á¾¾çÇÐ, ¸é¿ªÇÐ, °¨¿°ÇÐ µîÀÇ ºÐ¾ß¿¡¼­ ¿©·¯ ¹ÙÀÌ¿À¸¶Ä¿¸¦ ÀÌÇØÇÔÀ¸·Î½á º¸´Ù Á¤È®ÇÑ Áø´Ü°ú ¸ÂÃã Ä¡·á Àü·«À¸·Î À̾îÁú ¼ö ÀÖ´Â ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù.

¸ÖƼÇ÷º½º ¾î¼¼ÀÌÀÇ ¹Ì·¡¸¦ Á¿ìÇÒ ±â¼ú ¹ßÀüÀº ¹«¾ùÀΰ¡?

»ý¸í°øÇÐ ¹× ºÐÀÚÁø´ÜÇÐÀÇ ¹ßÀüÀº ¸ÖƼÇ÷º½º ¾î¼¼À̹ýÀ» ´õ¿í ¹Î°¨Çϰí, Á¤È®Çϰí, È®Àå °¡´ÉÇÑ °ÍÀ¸·Î º¯È­½Ã۰í ÀÖ½À´Ï´Ù. Â÷¼¼´ë ½ÃÄö½Ì(NGS) ±â¼ú°ú ¸¶ÀÌÅ©·Î¾î·¹ÀÌ Ç÷§ÆûÀÇ °³¹ß·Î ´ë·®ÀÇ À¯ÀüÀÚ ¹× ´Ü¹éÁú µ¥ÀÌÅ͸¦ µ¿½Ã¿¡ ºÐ¼®ÇÒ ¼ö ÀÖ´Â ´É·ÂÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, Çü±¤ ¹× È­Çй߱¤ °ËÃâ¹ýÀÇ ¹ßÀüÀ¸·Î ¸ÖƼÇ÷º½º ¾î¼¼ÀÌÀÇ ¹Î°¨µµ¿Í Á¤È®µµ°¡ Çâ»óµÇ¾î Àú³óµµÀÇ ¹ÙÀÌ¿À¸¶Ä¿¸¦ °ËÃâÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀΰøÁö´É(AI) ¹× ¸Ó½Å·¯´×°úÀÇ ÅëÇÕÀ» ÅëÇØ º¸´Ù Á¤±³ÇÑ µ¥ÀÌÅÍ ºÐ¼®ÀÌ °¡´ÉÇØÁ® ¿¬±¸ÀÚ¿Í ÀÓ»óÀǰ¡ º¹ÀâÇÑ ºÐ¼® °á°ú¸¦ º¸´Ù È¿°úÀûÀ¸·Î ÇØ¼®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀ¸·Î ÀÎÇØ µ¿¹ÝÁø´Ü, ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö, ¸ÂÃãÀÇ·á µîÀÇ ºÐ¾ß¿¡¼­ ¸ÖƼÇ÷º½º ¾î¼¼ÀÌÀÇ È°¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

°³ÀÎ ¸ÂÃãÇü ÀÇ·á·ÎÀÇ ÀüȯÀÌ ¸ÖƼÇ÷º½º ¾î¼¼ÀÌ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ¾î¶»°Ô ÃËÁøÇϰí Àִ°¡?

ȯÀÚº° À¯ÀüÀÚ, ºÐÀÚ, ȯ°æÀû ÇÁ·ÎÆÄÀÏÀ» ±â¹ÝÀ¸·Î ȯÀÚ °³°³Àο¡ ¸Â´Â Ä¡·á¸¦ Á¦°øÇÏ´Â ¸ÂÃãÀÇ·á Áõ°¡·Î ÀÎÇØ ¸ÖƼÇ÷º½º ¾î¼¼ÀÌ¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ÇÑ ¹ø¿¡ ¿©·¯ ¹ÙÀÌ¿À¸¶Ä¿¸¦ ºÐ¼®ÇÏ¿© ȯÀÚÀÇ °Ç°­ »óÅÂ¿Í Áúº´ »óŸ¦ º¸´Ù Á¾ÇÕÀûÀ¸·Î ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Á¾¾çÇп¡¼­ ¸ÖƼÇ÷º½º ¾î¼¼ÀÌÀº Ç¥Àû Ä¡·á¸¦ ¾È³»Çϴ ƯÁ¤ µ¹¿¬º¯ÀÌ ¹× À¯ÀüÀÚ ¹ßÇöÀ» ½Äº°ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÇϳªÀÇ °Ë»ç·Î ¿©·¯ Áúº´ °ü·Ã ¸¶Ä¿¸¦ °ËÃâÇÏ°í ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó ¿©·¯ °á°ú¸¦ µ¿½Ã¿¡ Æò°¡ÇÒ ¼ö ÀÖ°Ô µÇ¾î ÀǾàǰ °³¹ß ¹× ÀÓ»ó½ÃÇèÀÇ È¿À²¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³ÀÎ ¸ÂÃãÇü Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ³ë·ÂÀº ¸ÖƼÇ÷º½º ¾î¼¼ÀÌ ½ÃÀåÀÇ Å« ¼ºÀå µ¿·ÂÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¸ÖƼÇ÷º½º ¾î¼¼ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

¸ÖƼÇ÷º½º ¾î¼¼ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº ºÐÀÚÁø´ÜÀÇ ¹ßÀü, ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ÇÏÀ̽º·çDz Ç÷§Æû ¹× Çâ»óµÈ °ËÃâ ¹æ¹ýÀÇ °³¹ß°ú °°Àº ±â¼ú Çõ½ÅÀº ¸ÖƼÇ÷º½º ¾î¼¼ÀÌÀÇ Á¤È®µµ¸¦ Çâ»ó½ÃŰ°í ´õ ³ÐÀº ¹üÀ§ÀÇ ÀÀ¿ë ºÐ¾ß¿¡ Àû¿ëµÉ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ¾Ï ¹× ±âŸ º¹ÀâÇÑ ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿©·¯ ¹ÙÀÌ¿À¸¶Ä¿¸¦ ÀÌÇØÇÏ´Â °ÍÀÌ Áø´Ü°ú Ä¡·á¿¡ ÇʼöÀûÀÎ ¿¬±¸ ¹× ÀÓ»ó ÇöÀå¿¡¼­ ÀÌ·¯ÇÑ ºÐ¼®¹ýÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ¸¦ ƯÁ¤ Ä¡·á¹ý¿¡ ¸Â°Ô Á¶Á¤Çϱâ À§ÇØ ¸ÖƼÇ÷º½º ¾î¼¼ÀÌÀÌ »ç¿ëµÇ´Â µ¿¹Ý Áø´ÜÀÇ È®´ë·Î ÀÎÇØ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¦¾à °³¹ß, ƯÈ÷ ¹ÙÀÌ¿À¸¶Ä¿ Áß½ÉÀÇ ½Å¾à ÀÓ»ó½ÃÇè¿¡¼­ ¸ÖƼÇ÷º½º ¾î¼¼ÀÌÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦°ø(¼Ò¸ðǰ, ±â±â, ¼ÒÇÁÆ®¿þ¾î£¦¼­ºñ½º);À¯Çü(´Ü¹éÁú ¾î¼¼ÀÌ, ÇÙ»ê ¾î¼¼ÀÌ, ¼¼Æ÷ ±â¹Ý ¾î¼¼ÀÌ);ÃÖÁ¾»ç¿ëÀÚ(Á¦¾à£¦¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, º´¿ø£¦¿¬±¸±â°ü, ÂüÁ¶ ½ÇÇè½Ç, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 11°³»ç)

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Multiplex Assays Market to Reach US$6.0 Billion by 2030

The global market for Multiplex Assays estimated at US$4.1 Billion in the year 2024, is expected to reach US$6.0 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 9.6% CAGR

The Multiplex Assays market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Multiplex Assays Market - Key Trends & Drivers Summarized

What Are Multiplex Assays and How Are They Used in Research and Diagnostics?

Multiplex assays are advanced diagnostic tools that allow the simultaneous detection and analysis of multiple biological markers (such as proteins, genes, or other molecules) in a single sample. These assays are widely used in research, clinical diagnostics, and drug development to analyze complex biological processes or detect diseases with higher accuracy and efficiency. Unlike traditional assays that measure one analyte at a time, multiplex assays provide a comprehensive overview by assessing multiple targets simultaneously, thus saving time, reducing costs, and increasing data throughput. These assays are essential in fields like oncology, immunology, and infectious diseases, where understanding multiple biomarkers can lead to more accurate diagnoses and personalized treatment strategies.

What Technological Advances Are Shaping the Future of Multiplex Assays?

Advancements in biotechnology and molecular diagnostics are transforming multiplex assays, making them more sensitive, accurate, and scalable. The development of next-generation sequencing (NGS) technologies and microarray platforms has significantly enhanced the ability to analyze large volumes of genetic and protein data simultaneously. Furthermore, advances in fluorescent and chemiluminescent detection methods have improved the sensitivity and precision of multiplex assays, allowing for the detection of lower concentrations of biomarkers. Integration with artificial intelligence (AI) and machine learning is enabling more sophisticated data analysis, helping researchers and clinicians interpret complex assay results more effectively. These technological innovations are expanding the use of multiplex assays in areas such as companion diagnostics, biomarker discovery, and personalized medicine.

How Is the Shift Toward Personalized Medicine Driving the Demand for Multiplex Assays?

The growing trend toward personalized medicine, which tailors treatments to individual patients based on their unique genetic, molecular, and environmental profiles, is significantly boosting the demand for multiplex assays. These assays enable healthcare providers to analyze multiple biomarkers at once, offering a more comprehensive understanding of a patient’s health and disease status. In oncology, for example, multiplex assays are being used to identify specific mutations or gene expressions that can guide targeted therapies. The ability to detect and monitor several disease-related markers in a single test is also enhancing the efficiency of drug development and clinical trials, where multiple outcomes can be evaluated simultaneously. This push toward more personalized and precise healthcare is a major growth driver for the multiplex assays market.

What Are the Key Growth Drivers in the Multiplex Assays Market?

The growth in the multiplex assays market is driven by several factors, including advancements in molecular diagnostics, the rising prevalence of chronic diseases, and the increasing demand for personalized medicine. Technological innovations, such as the development of high-throughput platforms and enhanced detection methods, are making multiplex assays more accurate and accessible for a wider range of applications. The growing incidence of cancer and other complex diseases is also pushing the adoption of these assays in research and clinical settings, where understanding multiple biomarkers is critical for diagnosis and treatment. Additionally, the expansion of companion diagnostics, where multiplex assays are used to match patients with specific therapies, is further driving demand. The increasing use of multiplex assays in pharmaceutical development, especially in the context of biomarker-driven drug trials, is another significant factor contributing to market growth.

SCOPE OF STUDY:

The report analyzes the Multiplex Assays market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Consumables, Instruments, Software & Services); Type (Protein Assays, Nucleic Acid Assays, Cell-Based Assays); End-Use (Pharma & Biotech Companies, Hospitals & Research Institutes, Reference Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 11 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â